SuperworthChemomab Therapeutics shares outstanding CMMB
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Mar 31, 2023
- 55.2M
- On a year earlier
- −3.1%
- fewer shares
Chemomab Therapeutics had 55.2M diluted shares outstanding on average in Q1 FY23, the quarter to Mar 31, 2023.
That is 3.1% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2022 | 56.3M | −7% |
| FY2021 | 60.9M | +10406% |
| FY2019 | 579.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY23 | 55.2M | −3% | |
| Q4 FY22 | 56.3M | −7% | |
| Q3 FY22 | 57.2M | +0% | |
| Q2 FY22 | 57M | +6% | |
| Q1 FY22 | 57M | +46% | |
| Q4 FY21 | 60.9M | n/a | |
| Q3 FY21 | 57M | +64% | |
| Q2 FY21 | 54.1M | +67% | |
| Q1 FY21 | 39.2M | +21% | |
| Q3 FY20 | 34.8M | +5912% | |
| Q2 FY20 | 32.4M | +5496% | |
| Q1 FY20 | 32.4M | +7783% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Chemomab Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.